Tolterodine-warfarin drug interaction

Annals of Pharmacotherapy

Volumn 33, Issue 11, 1999, Pages 1173-1176

  Colucci, Vincent J ^a   Rivey, Michael P ^b  

^a UNIVERSITY OF MONTANA   (United States)

^b NONE

Author keywords

Interaction; Tolterodine; Warfarin

Indexed keywords

DIGOXIN; FLUOXETINE; LEVOFLOXACIN; MELATONIN; NORTRIPTYLINE; TOLTERODINE; VERAPAMIL; WARFARIN;

AGED; ARTICLE; CASE REPORT; DOSE RESPONSE; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNATIONAL STANDARD UNIT; MALE; PRIORITY JOURNAL; REFERENCE VALUE; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BENZHYDRYL COMPOUNDS; CEREBROVASCULAR ACCIDENT; CRESOLS; DRUG INTERACTIONS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; URINATION DISORDERS; WARFARIN;

EID: 0032701649     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.19025     Document Type: Article

References (11)

1. Hansten PD, Horn JR. Drug interactions analysis and management. Vancouver, WA: Applied Therapeutics, Inc., 1997:503-4.
2. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676-83.
3. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants. Chest 1998;114:445S-69S.
4. McEvoy GK, Litvak K, Welsh OH. Drug information 98. Bethesda, MD: American Society of Health-System Pharmacists, Inc., 1998:1156-63.
5. Package insert. Detrol (tolterodine tartrate). Kalamazoo, MI: Pharmacia & Upjohn Co., 1998.
6. Yacobi A, Udall JA, Levy G. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clin Pharmacol Ther 1976;19:552-8.
7. Kaminsky LS, Zhang ZY. Human P450 metabolism of warfarin. Pharmacol Ther 1997;73:67-74.
8. Michalets EL. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 1998;18:84-112.
9. Hutchinson TA, Lane DA. Assessing methods for causality assessment of suspected adverse drug reactions. J Clin Epidemiol 1989;42:5-16.
10. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
11. Liao S, Pallmer M, Fowler C, Nayak RK. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. J Clin Pharmacol 1996;36:1072-7.